475 studies found for:    "Hepatitis B, Chronic"
Show Display Options
Rank Status Study
21 Completed KRN7000 in Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: KRN7000
22 Completed Long-Term Lamivudine Therapy for Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Procedure: Blood Testing;   Procedure: Percutaneous Liver Biopsy;   Procedure: Lamivudine Therapy
23 Not yet recruiting Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Conditions: Hepatitis B;   Hepatitis B, Chronic
Intervention:
24 Recruiting Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy
Condition: Hepatitis B, Chronic
Intervention:
25 Completed
Has Results
PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)
Condition: Hepatitis B, Chronic
Intervention: Drug: pegylated interferon alpha-2b
26 Enrolling by invitation Use of TDF in Patients With Inactive Chronic Hepatitis B Infection
Condition: Hepatitis B, Chronic
Intervention: Drug: Tenofovir disoproxil fumarate
27 Active, not recruiting Telbivudine and Tenofovir in Men of Childbearing Age With Immune-tolerant Chronic Hepatitis B
Condition: Hepatitis B,Chronic
Intervention: Drug: Telbivudine and Tenofovir
28 Completed A Study to Assess DV-601 in Subjects With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: DV-601;   Drug: Entecavir
29 Active, not recruiting Telbivudine and Tenofovir in Women of Childbearing Age With Immune-tolerant Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: Telbivudine and Tenofovir
30 Active, not recruiting Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: REP 2139-Ca;   Drug: pegylated interferon;   Drug: entecavir
31 Completed A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]
32 Unknown  Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: interferon α plus nucleoside analogue;   Drug: interferon α
33 Recruiting Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease
Conditions: Inflammatory Bowel Disease;   Crohn Disease;   Ulcerative Colitis;   Rheumatic Diseases;   Hepatitis B, Chronic
Intervention: Other: HBV DNA level monitoring
34 Completed Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients
Condition: Hepatitis B, Chronic
Intervention:
35 Completed An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)
Condition: Hepatitis B, Chronic
Intervention: Drug: Adefor dipivoxil
36 Recruiting Study of ARC-520 in Patients With Chronic Hepatitis B Virus
Condition: Hepatitis B, Chronic
Interventions: Drug: ARC-520;   Drug: Placebo
37 Completed An Expanded Access Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Intervention: Drug: peginterferon alfa-2a [Pegasys]
38 Completed
Has Results
Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
Conditions: Hepatitis;   Hepatitis B, Chronic;   Cirrhosis
Interventions: Drug: Telbivudine;   Drug: Lamivudine;   Drug: Placebo
39 Active, not recruiting
Has Results
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Condition: Hepatitis B, Chronic
Intervention: Drug: Entecavir
40 Completed A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)
Condition: Hepatitis B, Chronic
Intervention: Drug: Peginterferon alfa-2a

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years